Workflow
Earnings Estimate Revision
icon
Search documents
Insights Into Hancock Whitney (HWC) Q2: Wall Street Projections for Key Metrics
ZACKS· 2025-07-10 14:16
Core Viewpoint - Analysts project Hancock Whitney (HWC) will report quarterly earnings of $1.34 per share, a 2.3% increase year over year, with revenues expected to reach $371.26 million, up 3.2% from the same quarter last year [1]. Earnings Estimates - Changes in earnings estimates are crucial for predicting investor reactions to the stock, with empirical studies showing a strong relationship between earnings estimate revisions and short-term stock price performance [2]. Key Metrics Projections - Analysts expect the 'Net interest margin (TE)' to be 3.5%, up from 3.4% in the same quarter last year [4]. - The 'Efficiency Ratio' is projected at 55.9%, compared to 56.2% a year ago [4]. - 'Average Balance - Total interest earning assets' is expected to reach $32.05 billion, down from $32.54 billion in the same quarter last year [5]. - 'Total nonperforming loans' are estimated at $106.46 million, up from $86.25 million a year ago [5]. - 'Total nonperforming assets' are projected to be $138.95 million, compared to $88.37 million in the same quarter last year [6]. - 'Total Noninterest Income' is forecasted at $96.84 million, up from $89.17 million a year ago [6]. - 'Net interest income (TE)' is expected to reach $278.55 million, compared to $273.26 million in the same quarter last year [7]. - 'Bank card and ATM fees' are estimated at $21.14 million, down from $21.83 million a year ago [8]. - 'Investment and annuity fees and insurance commissions' are projected at $10.47 million, up from $9.79 million last year [9]. - 'Other income' is expected to be $15.64 million, compared to $13.26 million a year ago [9]. Stock Performance - Hancock Whitney shares have increased by 11.6% in the past month, outperforming the Zacks S&P 500 composite's 4.4% increase, with a Zacks Rank 2 (Buy) indicating expected outperformance in the near term [10].
What Analyst Projections for Key Metrics Reveal About JPMorgan Chase & Co. (JPM) Q2 Earnings
ZACKS· 2025-07-10 14:16
Core Viewpoint - Analysts project that JPMorgan Chase & Co. will report quarterly earnings of $4.51 per share, a 2.5% increase year over year, with revenues expected to decline by 12.7% to $43.81 billion [1] Earnings Estimates - The consensus EPS estimate has been revised upward by 1.5% in the past 30 days, indicating a reassessment by covering analysts [2] - Changes in earnings estimates are crucial for predicting investor reactions, with empirical studies showing a strong relationship between earnings estimate revisions and short-term stock performance [3] Revenue Projections - Analysts forecast 'Consumer & Community Banking - Revenue By Line of Business - Card Services & Auto' to reach $6.76 billion, reflecting a 12.6% year-over-year increase [5] - 'Consumer & Community Banking - Revenue By Line of Business - Home Lending' is projected at $1.28 billion, indicating a 2.8% decline from the previous year [5] - 'Total Net Revenue - Line of Business Net Revenue - Asset & Wealth Management' is expected to be $6.09 billion, a 15.9% increase year over year [6] - 'Total Net Revenue - Line of Business Net Revenue - Consumer & Community Banking' is estimated at $18.55 billion, showing a 4.8% increase from the prior year [6] Key Metrics - 'Consumer & Community Banking - Revenue By Line of Business - Banking & Wealth Management' is projected to be $10.50 billion, a 1.2% increase year over year [7] - Analysts expect 'Book value per share' to be $122.72, up from $111.29 in the same quarter last year [7] - 'Total Interest Earning Assets - Average Balance' is anticipated to reach $3648.52 billion, compared to $3509.73 billion in the same quarter last year [8] - 'Total Non-Performing Assets' is projected at $9.73 billion, up from $8.42 billion in the previous year [8] Capital Ratios - The 'Tier 1 leverage ratio' is expected to be 7.1%, slightly down from 7.2% reported in the same quarter last year [9] - 'Total Non-Performing Loans' is estimated at $9.14 billion, compared to $7.79 billion in the same quarter last year [9] - The average prediction for 'Tier 1 Capital Ratio' is 16.3%, down from 16.7% in the previous year [10] - The estimated 'Total Capital Ratio' is 17.7%, compared to 18.5% reported in the same quarter last year [10] Stock Performance - JPMorgan Chase & Co. shares have increased by 5.6% in the past month, outperforming the Zacks S&P 500 composite's 4.4% increase [11]
Seeking Clues to Wells Fargo (WFC) Q2 Earnings? A Peek Into Wall Street Projections for Key Metrics
ZACKS· 2025-07-10 14:16
In its upcoming report, Wells Fargo (WFC) is predicted by Wall Street analysts to post quarterly earnings of $1.40 per share, reflecting an increase of 5.3% compared to the same period last year. Revenues are forecasted to be $20.7 billion, representing no change year over year.The consensus EPS estimate for the quarter has undergone an upward revision of 0.6% in the past 30 days, bringing it to its present level. This represents how the covering analysts, as a whole, have reassessed their initial estimates ...
Can Prairie Operating Co. Recover From Its 52-Week Low?
ZACKS· 2025-07-07 12:36
Core Insights - Prairie Operating Co. (PROP) has experienced a significant decline in stock price, dropping 61% over the past year, reaching a 52-week low of $2.74, which is notably worse than the 19% decline in the broader Zacks Oil & Gas US Exploration & Production industry [2][9] - The company's aggressive growth strategy in the northern DJ Basin is facing substantial financial and operational challenges, raising concerns about its investment viability [5][6] Financial Outlook - PROP's financial stability is compromised by substantial equity dilution, with the share count nearly doubling over the past year and further dilution expected due to in-the-money warrants and preferred stock conversions [7] - The company has a negative operating cash flow profile, which is eroding balance sheet strength and necessitating dilutive actions to manage debt [7] - Analysts have significantly reduced EPS estimates for 2025 and 2026, with a 32% drop for 2025 and a 20% drop for 2026, indicating a bearish outlook [13] Operational Challenges - PROP aims to increase production from approximately 7,000 barrels of oil equivalent per day (BOE/d) to over 30,000 BOE/d within a year, representing a nearly 300% increase, which poses significant execution risks [8][10] - The company's concentrated focus on the DJ Basin, unlike more diversified competitors, introduces higher single-basin execution risks, especially given the potential for delays and cost overruns [10][12] Industry Context - The Zacks Oil & Gas US Exploration & Production industry is currently ranked in the bottom 38% of all industries, reflecting a challenging environment for companies within this sector [13] - The U.S. Energy Information Administration forecasts a decline in Brent crude prices, which could adversely affect PROP's revenue and cash flow, particularly given its capital-intensive drilling plans [16] Conclusion - Given the combination of rampant equity dilution, high execution risk, poor earnings surprise history, and unfavorable industry conditions, PROP's investment worthiness is currently rated low, making it an unappealing option for investors seeking stability [18]
Stay Ahead of the Game With Helen of Troy (HELE) Q1 Earnings: Wall Street's Insights on Key Metrics
ZACKS· 2025-07-04 14:16
Core Viewpoint - Analysts expect Helen of Troy (HELE) to report quarterly earnings of $0.91 per share, reflecting an 8.1% year-over-year decline, with revenues projected at $399.33 million, down 4.2% from the previous year [1]. Earnings Estimates - Revisions to earnings estimates are crucial indicators for predicting investor actions regarding the stock, with empirical research showing a strong correlation between earnings estimate trends and short-term stock performance [2]. - The consensus EPS estimate for the quarter has remained unchanged over the last 30 days, indicating analysts' reassessment of their initial estimates [1]. Key Metrics - Analysts predict 'Net sales- Beauty & Wellness' will reach $220.42 million, indicating a year-over-year increase of 0.9% [4]. - 'Net sales- Home & Outdoor' is expected to be $178.91 million, suggesting a decline of 9.9% year over year [4]. - The consensus estimate for 'Adjusted operating income (non-GAAP)- Beauty & Wellness' is $20.55 million, down from $21.88 million in the same quarter last year [4]. - 'Adjusted operating income (non-GAAP)- Home & Outdoor' is projected at $22.84 million, compared to $21.07 million reported in the same quarter last year [5]. Stock Performance - Shares of Helen of Troy have returned +16.9% over the past month, outperforming the Zacks S&P 500 composite's +5.2% change [5]. - Despite recent performance, HELE holds a Zacks Rank 5 (Strong Sell), indicating expectations of underperformance relative to the overall market in the near future [5].
Melco (MLCO) Soars 11.5%: Is Further Upside Left in the Stock?
ZACKS· 2025-07-02 15:20
Group 1 - Melco Resorts (MLCO) shares increased by 11.5% to close at $8.06, with notable trading volume compared to typical sessions, and a 15.1% gain over the past four weeks [1][2] - Macau regulators reported a 19% year-over-year increase in gaming revenue for June, totaling 21.06 billion Macanese patacas (approximately $2.61 billion), indicating strong post-pandemic recovery in the region [2] - The company is expected to report quarterly earnings of $0.03 per share, reflecting a 50% year-over-year decline, while revenues are projected to be $1.2 billion, up 3.6% from the previous year [3] Group 2 - The consensus EPS estimate for Melco has been revised 50% higher in the last 30 days, suggesting a positive trend that may lead to price appreciation [4] - Melco currently holds a Zacks Rank of 2 (Buy), indicating favorable market sentiment [5] - In comparison, Churchill Downs (CHDN) from the same gaming industry has a Zacks Rank of 4 (Sell) and reported a 3.2% increase in its stock price [5][6]
SoFi Technologies (SOFI) Surges 6.0%: Is This an Indication of Further Gains?
ZACKS· 2025-07-01 13:46
Company Overview - SoFi Technologies, Inc. (SOFI) shares increased by 6% to $18.21 in the last trading session, with a notable trading volume and a total gain of 29.2% over the past four weeks, driven by strong member and product growth, particularly in the SoFi Money business [1] Earnings Expectations - The company is projected to report quarterly earnings of $0.06 per share, reflecting a year-over-year increase of 500%, with revenues expected to reach $803.09 million, a 34.5% rise from the same quarter last year [2] - The consensus EPS estimate for SoFi has been revised 5% higher in the last 30 days, indicating a positive trend that typically correlates with price appreciation [3] Industry Context - SoFi Technologies is categorized under the Zacks Financial - Miscellaneous Services industry, which includes Atlanticus Holdings Corporation (ATLC), another company in the same sector that saw a 2.2% increase in its stock price, closing at $54.75, and has returned 9.2% over the past month [4]
PINE vs. EGP: Which Stock Should Value Investors Buy Now?
ZACKS· 2025-06-30 16:41
Core Insights - Investors are considering Alpine Income (PINE) and EastGroup Properties (EGP) for potential value opportunities in the REIT and Equity Trust - Other sector [1] Valuation Metrics - Alpine Income has a Zacks Rank of 2 (Buy), indicating a positive earnings outlook, while EastGroup Properties has a Zacks Rank of 3 (Hold) [3] - PINE has a forward P/E ratio of 8.47, significantly lower than EGP's forward P/E of 18.81 [5] - The PEG ratio for PINE is 1.41, while EGP's PEG ratio is 3.70, suggesting PINE is more favorably valued in terms of expected EPS growth [5] - PINE's P/B ratio is 0.8, compared to EGP's P/B of 2.63, indicating PINE is undervalued relative to its book value [6] - Based on these metrics, PINE has a Value grade of B, while EGP has a Value grade of F, highlighting PINE's superior valuation [6] Conclusion - PINE is positioned as the better value option due to its solid earnings outlook and favorable valuation metrics compared to EGP [7]
Gear Up for Constellation Brands (STZ) Q1 Earnings: Wall Street Estimates for Key Metrics
ZACKS· 2025-06-27 14:16
Core Viewpoint - Constellation Brands is expected to report a decline in quarterly earnings and revenues, indicating potential challenges in its business performance [1][2]. Earnings Estimates - Analysts predict quarterly earnings of $3.37 per share, a decrease of 5.6% year-over-year [1]. - Revenue is forecasted at $2.57 billion, reflecting a year-over-year decrease of 3.4% [1]. - The consensus EPS estimate has been revised down by 0.5% in the last 30 days [2]. Key Metrics - Estimated 'Net Sales- Wine and Spirits' is projected at $297.74 million, a significant decline of 23.5% year-over-year [5]. - 'Net Sales- Beer' is expected to reach $2.27 billion, showing a minimal decrease of 0.1% year-over-year [5]. - 'Operating Income- Wine and Spirits' is anticipated to be $12.38 million, down from $59.70 million in the same quarter last year [5]. - 'Operating Income- Beer' is projected at $899.70 million, compared to $941.60 million reported in the same quarter last year [6]. Stock Performance - Shares of Constellation Brands have decreased by 10.2% over the past month, contrasting with a 6% increase in the Zacks S&P 500 composite [7]. - The company holds a Zacks Rank 3 (Hold), suggesting it is expected to perform in line with the overall market in the near future [7].
Ocular Therapeutix (OCUL) Moves 8.6% Higher: Will This Strength Last?
ZACKS· 2025-06-25 16:16
Company Overview - Ocular Therapeutix (OCUL) shares increased by 8.6% to $9.09 in the last trading session, with a notable trading volume, and have gained 14.7% over the past four weeks [1][2] Pipeline and Product Development - The price rise is linked to positive investor sentiment regarding Ocular's product candidate Axpaxli, which is in late-stage studies for treating wet age-related macular degeneration, diabetic retinopathy, diabetic macular edema, and other retinal diseases [2] Financial Performance Expectations - The company is projected to report a quarterly loss of $0.35 per share, reflecting a year-over-year decline of 45.8%, with expected revenues of $13.55 million, down 17.6% from the previous year [3] - The consensus EPS estimate for the quarter has been revised 1.2% higher in the last 30 days, indicating a potential for price appreciation [4] Industry Context - Ocular Therapeutix is part of the Zacks Medical - Drugs industry, where Takeda Pharmaceutical Co. (TAK) also operates, having seen a 2.5% increase to $15.08 in the last trading session [5] - Takeda's consensus EPS estimate remains unchanged at $0.47, representing a year-over-year decline of 16.1%, and it currently holds a Zacks Rank of 4 (Sell) [6]